Psoriasis Vulgaris (PV) Exacerbation in Acute Myeloid Leukemia(AML) Patient Treated with Cytarabine/Daunorubicin (C/D)

Authors

  • Kesya Kimberly Faculty of Medicine and Health Science, University of Pelita Harapan, Indonesia Author
  • Windy Keumala Budianti Department of Dermatology and Venereology, University of Indonesia, Indonesia Author
  • Faras Qodriah Sani Faculty of Medicine, Universities YARSI, Indonesia Author
  • Nahdah Aidah Faculty of Medicine, Universities Pembangunan National, Indonesia Author

DOI:

https://doi.org/10.47363/JDMRS/2024(5)167

Keywords:

Acute Myeloid Leukemia, Cytarabine, Daunorubicin, Psoriasis Vulgaris

Abstract

Adverse reactions associated with chemotherapeutic agents to treat acute leukemia such as cytarabine and daunorubicin (C/D) have been reported regularly, however, psoriasis vulgaris is a rare adverse event. We report a 46-year-old Indonesian man presented with multiple erythema scaly plaques on his trunk for one month. He was diagnosed with acute myeloid leukemia (AML) 4 months ago, and received remission-induction chemotherapy for AML with a high-dose combination of C/D. 

Author Biographies

  • Kesya Kimberly, Faculty of Medicine and Health Science, University of Pelita Harapan, Indonesia

    Faculty of Medicine and Health Science, University of Pelita Harapan, Indonesia

  • Windy Keumala Budianti, Department of Dermatology and Venereology, University of Indonesia, Indonesia

    Department of Dermatology and Venereology, University of Indonesia, Indonesia

  • Faras Qodriah Sani, Faculty of Medicine, Universities YARSI, Indonesia

    Faculty of Medicine, Universities YARSI, Indonesia

  • Nahdah Aidah, Faculty of Medicine, Universities Pembangunan National, Indonesia


    Faculty of Medicine, Universities Pembangunan National, Indonesia

Downloads

Published

2024-10-22

Issue

Vol. 5 No. 10 (2024): Volume 5 Issue 10

Section

Articles